FindTrial
Sign In

To Assess CT Chest finding of Post-covid Pneumonia Patient

To Assess CT Chest finding of Post-covid Pneumonia Patient

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/029733
Enrollment
50
Registered
2020-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Not Applicable: Not Applicable Intervention2: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Nil Patel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age > 18 years Willing to participate and give consent Confirm Covid Positive by RTPCR or Rapid Antigen Test All Patients Recovered from Covid 19 Positive Pneumonia after 1 months

Exclusion criteria

Exclusion criteria: Age HIV/AIDS Active and Old Pulmonary kochâ??s Malignancy Bronchiectasis ILD and other Chronic Respiratory Condition

Design outcomes

Primary

MeasureTime frame
To Assess CT Chest finding of Post-covid Pneumonia PatientTimepoint: 6 Months—

Secondary

MeasureTime frame
To Assess the Effectiveness of Perfenidone and/or Prednisolone in prevention of lung fibrosis in Post-Covid Pneumonia PatientTimepoint: 6 Months—

Countries

India

Contacts

Public ContactDr Anand Patel

Gmers Medical College And Hospital,Gotri,Vadodara

dranandkpatel@gmail.com9879771079

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026